Tissue factor (TFI is a 48-kD transmembrane glycoprotein that triggers the extrinsic pathway of blood coagulation by interacting with the plasma coagulation factor VI1 (WII). TF is also a true receptor in that a cellular signal is generated when activated Wll (Wlla) binds to TF. For both of these functions, the cellular surface distribution of TF is important, since Wll is primarily available on the apical side of vascular endothelial cells and on the basolateral side of epithelial cells lining the internal and external surfaces. We show that ISSUE FACTOR (TF) is a 48-kD transmembrane glycoprotein that triggers the extrinsic pathway of blood coagulation by interaction with plasma coagulation factor VI1 (FVII)."4 The membrane-bound complex of TF and activated FVII (FVIIa) activates zymogen factors IX and X, which in turn initiate a series of reactions culminating in the deposition of fibrin. TF, which is not normally expressed in tissues that are in direct contact with circulating blood,5" is thought to form a protective lining around tissues and blood vessels exposed to the plasma factors only in the event of tissue damage. However, in monocytes/macrophages* and endothelial cells: TF synthesis can be induced by endotoxins, inflammatory cytokines, and a number of other agents and conditions, both physiologic and nonphysiologic."
ISSUE FACTOR (TF) is a 48-kD transmembrane glycoprotein that triggers the extrinsic pathway of blood coagulation by interaction with plasma coagulation factor VI1 (FVII)."4 The membrane-bound complex of TF and activated FVII (FVIIa) activates zymogen factors IX and X, which in turn initiate a series of reactions culminating in the deposition of fibrin. TF, which is not normally expressed in tissues that are in direct contact with circulating blood,5" is thought to form a protective lining around tissues and blood vessels exposed to the plasma factors only in the event of tissue damage. However, in monocytes/macrophages* and endothelial cells: TF synthesis can be induced by endotoxins, inflammatory cytokines, and a number of other agents and conditions, both physiologic and nonphysiologic."
To understand the (patho)physiologic role of inducible endothelial TF expression both as a procoagulant trigger and as a receptor,' it is important to know whether TF is exposed to circulating blood and thus to its ligand, WIT. Mature human TF consists of 263 amino acids organized into three domains: a 219-amino acid N-terminal extracellular domain organized into two modules, a 23-amino acid transmembrane domain, and a 21 -amino acid cytoplasmic domain.",'* To investigate if any sorting signals were present in the TF cytoplasmic domain, we prepared a construct coding for a cytoplasmic tail-truncated TF molecule. We report here studies on the polar distribution of wild-type TF antigen in human umbilical vein endothelial cells (HUVEC) and of wild-type and truncated TF antigen and activity in MadinDarby canine kidney epithelial cells (MDCK).
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MATERiALS AND METHODS
Materials
Cell Culture media and supplements were obtained from BioWhittaker (Walkerville, MD), except fetal calf serum (FCS), which was from Biological Industries (Kibbutz Beth Haemek, Israel). Tissue culture plastics (including Anapore and Transwell membrane inserts) was obtained from Nunc (Roskilde, Denmark) and Costar (Cambridge, MA). TF was isolated from human brain essentially as described by Hjort.' Purified factor X (FX), bovine serum albumin (BSA), Hoechst 33258, HEPES, propidium iodide, Brefeldin A (BFA), and Geneticin (G418) were obtained from Sigma (St Louis, MO). Recombinant human FVIIa, interleukin-10, heparin, and anti-TFPI were kindly donated by Professor U. Hedner, Dr M. Ezban, and Dr T. Jmgensen, Novo-Nordisk (Bagsvcrd, Denmark). Annexin V purified from human placenta was from Alexis Corp (Laufelfinger, Switzerland). Dr W.L. van from Nycomed (Oslo, Norway). The serine protease chromogenic substrate S-2288 was from Chromogenix (Molndal, Sweden). The neutralizing murine antihuman monoclonal antibodies were purchased from American Diagnostica Inc (Greenwich, CT) (4504 and 4507) or were produced and kindly donated by Dr S . Carson (htfl).13 FITC-conjugated rabbit anti-mouse Ig F(ab'), was from DAKO (Glostrup, Denmark). The TF ELISA kit was from American Diagnostica. Iz5I, PD-IO columns, streptavidin-biotin-HRP, and'ECL reagents were from Amersham (Amersham, UK). Sulpho-NHS-biotin and Iodo-beads were from Pierce (Rockford, IL). Sheep anti-mouse Ig-coated magnetic beads were from Dynal (Oslo, Norway). The mammalian expression vector pcDNA3 was from Invitrogen (San Diego, CA). Soluene and scintillation fluid were from Packard (Groningen, The Netherlands). Human TF cDNA was kindly provided by Dr J.H. Morrissey.
Vector Construction
To see if the cytoplasmic domain of the TF molecule contained any transport signal, we constructed hTFI.245, a recombinant TF molecule lacking the cytoplasmic domain, with the exception of the three membrane-proximal amino acids for membrane anchoring by cysteine-palmitatektearate thioester binding.I4
The hTF,.245 construct was designed using an overlap extension method of splicing two otherwise noncompatible DNA fragments. The primers used were p1 GACAGCCAACAATTCAGAGTTIT (forward), p2 AGTGCTTCCTTTAACACTTGTGTAGAGATA-TAGCCAGGA (reverse), p3 TCTACACAAGTGITAAAGGAA-GCACTGTTGGAGC (forward), and p4 CTAGAAATGCACCCA-ATTTCCT (reverse), all given 5'-3'. Two internal primers, p2 and p3, both pointing away from the sequence to be deleted, were placed just outside the sequence coding for the TF cytoplasmic domain. Each had a 13-bp tail (underlined) complementary to the sequence on the other side of the region to be deleted. Individual amplification with pl + p2 and p3 + p4, isolation from excess primer, pooling, denaturation, annealing of the 26-bp overlap created by the two 13-bp overhangs, and a final fill-in polymerization yielded a fragment coding for the region up to cysteine 245 dxectly followed by a stop codon and the 3' untranslated region of the cDNA. This fragment was amplified with primers 1 + 4, digested with NcoI and HpaI, and subcloned into the NcoI and HpaI sites of wild-type human TF. The entire PCR-amplified sequence and the splice junctions were verified by restriction digests and sequencing.
This truncated TF construct (hTF1.245) and wild-type human TF cDNA (hTF,.263) were cloned into the mammalian expression vector pcDNA3. This vector contains the human cytomegalovirus promoter for high-level expression and a neomycin gene for selection of stable transfectants.
Transfection
All transfections were made using standard calcium phosphate coprecipitation procedures with glycerol shock. Clones with stably integrated constructs were selected with 500 pg/mL (3418. Selection of transfectants for total TF expression was made by mixing cell homogenates (50 pL) with human plasma (50 pL) and 30-mmoVL Ca" (50.pL) and recording clotting time as previously described."
Cell Preparation and Culture
MDCK strain 1 and COS-l cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% inactivated fetal calf serum (FCS), L-glutamine, and antibiotics. Stably transfected cells were maintained in the above medium supplemented with 100 pglmL G418. For polarity studies, MDCK cells were plated either at low density (70,000 cells/cm2 membrane) to obtain tight junctions 4 to 5 days after plating or at high density (300,000 cells/ cm2 membrane) to obtain tight junctions 2 to 3 days after plating, in tissue culture-treated filter chambers 1.2 or 2.45 cm in diameter and with 0.45 or 3 pm pore size (Transwell; Costar). The plating density did not affect TF distribution. The medium was changed every day, and the experiments were performed 1 to 2 days after the formation of tight junctions. MDCK cells of high passage number were not used, due to their reduced ability to form tight junctions.
Tight junction formation was assessed by resistance measurements across the membrane using a Millipore Ohmmeter. A steep increase in electrical resistance accompanied the formation of junctional complexes. Leakage controls were also made using radioactive inulin. There was no detectable leakage of FXa. Leakage of '2sI-labeled antibody was less than 0.5% after 1.5 hours' incubation on ice.
Where indicated, cells were incubated with 5 pg/mL BFA in growth medium for 6 or 24 hours and during the subsequent experiment.
HUVEC were isolated and cultured, and TF synthesis was induced with 1 0 0 U/mL IL-10 as previously described.16 The cells were grown on transparent permeable membranes to allow ligbt-microscopic observation. Leakage of 1251-labeled antibody across the tight cell layers was, on average, 2% over a 1.5-hour incubation period on ice. Other tests to confirm the integrity of the tight monolayer were performed as recently described.I6 DNA level was measured by Hoechst 33258 fluorometry. Immunofluorescence on cover slips was performed using subconfluent cell layers.
Determination of TF ActiviQ
Total TF activity in cell homogenates. Total TF activity in frozen, thawed, and homogenized cells was measured using a standard clotting assay with human plasma and 30 mmol/L CaCl2.I5 TF activity was determined from a standard curve made with a human brain TF preparation' that clotted human plasma in 14 to 15 seconds. This was taken to represent 100 U TF (UTF)/mL. One unit TF corresponded to 1.5 ng TF as determined by the IMUBIND TF ELISA kit. The values are expressed as UTF/mg cell protein. " Surface TF activity determined by the Xa chromogenic substrate assay was related to total TF activity determined by the clotting assay by reference to a common standard curve made with the human brain TF preparation.
FX activating activity of TFNIIa on the cell s u~a c e . The method used was based on the activation of FX by the TF-VIIa-Ca2+ membrane complex. The reaction between FXa and its chromogenic peptide substrate was monitored by the increase in OD4o5 over 20 minutes. The cells were washed carefully thrice and incubated with BSA ( 5 mg/mL) in veronal-buffered saline (VBS), pH 7.4, for 30 minutes at 37°C with shaking at 100 rpm, in the presence or absence of a neutralizing monoclonal antibody (American Diagnostica anti-TF antibody no. 4507) as appropriate. This antibody neutralized human TF, but did not alter the endogenous canine TF activity in untransfected MDCK cells. CaC12 was then added to a final concentration of 4 mmol/L. The compartments to be tested for TF expression were supplied with FVIIa (10 U/mL) and FX (0.5 U/mL), and the culture trays were again incubated with shalung at 100 rpm and 37°C. At 5 , 10, 15, and 20 minutes, samples of 20 p L were taken from each compartment and added to a microtiter plate containing 150 pL VBS, pH 7.4, with 10 mmol/L EDTA per well to stop the reaction. After thorough mixing, 20 pL (80 nmol) FXa-l substrate was added to each sample. The ODas was monitored in a Titertek Multiscan at 10-minute intervals for 60 minutes, and AODm5 was calculated. A linear increase in OD,os over this period confirmed sufficient amounts of substrate. FVIIa and FX were also titrated to give linear curves within the time span of the assay. Controls with human brain TF demonstrated that the system was linear with increasing TF concentration under the established conditions. The first incubation (with cells, FVIIa, and FX) was standardized to IO minutes, and the second (with chromogenic substrate) to 20 minutes. The linearity of both reactions was controlled in each experiment. Under these conditions, a AODa5 value of 1 .O corresponded to 0.7 I UTF ( I .I ng TF) and the three standard curves (TF antigen, TF activity, and FX activating activity) were colinear.
Amidolytic activity of TFNIIa on the cell surface. The cell surface activity of the TFNIIa complex toward the peptide substrate S-2288 was determined essentially as described by Le et al.'* Cell monolayers were incubated with 20 nmol/L VIIa in HEPES-buffered saline ([HBS] 136 mmol/L NaCl, 5 mmol/L CaCI,, 5 mmollL KC1, 1.2 mmol/L MgCIZ, 11 mmol/L Bacto-dextrose, 10 mmol/L HEPES, and 1% BSA, pH 7.4) for 1 hour at 37°C to saturate TF specific binding. Following washing, the chromogenic substrate S-2288 was added to a final concentration of 0.5 mmoliL in HBS. After incubation at 37°C for 1 hour, 200-pL aliquots were transferred to a 96-well microtiter plate and absorbance at 405 nm was measured. Controls were cells not receiving VIIa and cells preincubated with a neutralizing anti-hTF monoclonal antibody (4504). The values are expressed as AOD,,/hour.mg cell protein." Comparisons of this peptidolytic activity of TF/rFVIIa complexes on the cell surface to complexes formed using isolated brain TF/rFVIIa showed that with otherwise equal TF activities and antigen levels, isolated human brain TF demonstrated threefold to fourfold lower specific activity toward the chromogenic substrate. The cause remains unexplained.
Immunoj3uorescence Microscopy
For staining of TF on IL-10-induced HUVEC, cells on cover slips were fixed in absolute ethanol, incubated for 1 hour at 37°C with primary antibody (4 pg/mL htfl in PBS with 1% BSA) and for l hour at 37°C with the rabbit antimouse FITC-conjugated antibody (25 pg/mL in PBS). Propidium iodide (100 ng/mL) was added during the last 10 minutes of the last incubation. Cells were rinsed four to five times in PBS between each step. A final rinse was made in PBS, pH 8. Controls of unperturbed HUVEC were included, with no evidence of nonspecific binding. polyclonal goat antiserum to human TFPI-l at a 1:500 dilution in PBS with 0.1% BSA on either the apical or basolateral side for 1 hour at 37°C. The cells were rinsed in PBS at 37°C. and FITCconjugated antigoat antiserum at 1:50 in PBSlBSA was applied for 30 to 45 minutes at 37°C. Staining with an irrelevant polyclonal antibody (anti-von Willebrand factor) was used as a control. Other controls were filters without cells incubated with medium and filters with cells stained with the second antibody only.
To detect endogenous or binding of exogenous Annexin V, the following procedures were used at 4°C. Transfected or untransfected MDCK cells and HUVEC (with or without induction of TF synthesis) were first washed thrice in HEPES buffer with 5 mmoVL CaC12 to conserve bound Annexin V or with HEPES buffer containing 1 mmol/L EDTA to remove it. (HEPES buffer consists of 25 mmoU L HEPES, 135 mmol/L NaCI, 5 mmoVL KCI, 0.01% wt/vol glucose, and 0.3% wt/vol BSA, pH 7.4.) The cells were then incubated with Annexin V or FITC-conjugated Annexin V both at a final concentration of 142 nmol/L, or a polyclonal rabbit antibody to Annexin V as appropriate, for 1 hour at 4°C. In the latter case, a FITC-conjugated goat antirabbit antiserum was used for detection. An irrelevant polyclonal antibody (raised in rabbit against human von Willebrand factor) that did not stain MDCK cells served as control.
'2'I-Labeling and Cell Surface Binding of FVIIa and AntihTF Monoclonal Antibodies
Factor VIIa and two different murine monoclonal antibodies to TF (htfl or American Diagnostica no. 4504) were labeled with 0.5 mCi 'zsI/lOO pg protein using Iodo-beads, obtaining specific activities of 2 to 4 X lo6 c p d p g . Free iodine was removed by running labeled proteins through a PD 10 column.
Cells were washed in ice-cold Tris-buffered saline, pH 7.5, containing l mmol/L calcium chloride and 0.5 mmol/L magnesium chloride (TBS+). The amount of monoclonal antibody necessary to saturate the TF-specific binding sites was titrated in preliminary experiments. The cells were then incubated with labeled monoclonal antibody (2.5 pg/mL), saturating the TF-specific binding in TBS+ (RPM1 for HUVEC) + 0.5% BSA for 1.5 hours on ice. The cells were washed extensively in TBS+, and the filters were cut out and immersed in Soluene before addition of scintillation fluid and counting in a Packard Tri-Carb Liquid Scintillation Analyzer. The number of binding sites were determined by relating the filter count (cpm) (background subtracted) to the specific activity of the antibody or FVIIa (cpdmolecule) after correction for isotope decay.
Nonspecific binding of FVIIa to the cell surfaces was controlled in experiments where 'ZSI-FVIIa was allowed to bind in the presence or absence of a 50-fold molar excess of cold FVIIa. The difference in total 12sI-FVIIa bound was taken to represent the specific binding.
The surface to total antigen ratio in MDCK cells was determined by comparison of apical and basolateral antibody binding to intact monolayers on Transwells to binding to monolayers on Transwells opened by 30 minutes' exposure to 100% ethanol on ice. Binding was as above, except that 5 pg/mL rather than 2.5 pg/mL '251-labeled antibody was used.
Cell Surface Biotinylation
Biotinylation of apical and basolateral surfaces was performed essentially as described by Sargiacomo et al. '9 All steps of the procedure prior to sample boiling were performed on ice. Cells were washed with PBS, pH 7.4, containing 1 mmoVL calcium and 0.5 mmoVL magnesium (PBS+). They were then incubated twice with 0.5 mg/mL freshly made sulpho-NHS-biotin in PBS+ for 20 minutes, in the apical or basolateral compartment as appropriate. The cells were washed, and excess free biotin was removed by incubating for 10 minutes in PBS+ with 50 mmol/L m C 1 (pH 7.1). After extensive washing, the filters were cut out, and cells were lysed in 1 mL lysis buffer (150 mmoVL NaC1, 20 mmol/L Tris, pH 8, 10 mmol/L EDTA, 1% Triton X-100,0.2% BSA, 1 mmol/L PMSF, 10 pg/mL aprotinin, 10 pg/mL leupeptin, 10 pg/mL antipain, 10 pgl mL chymostatin, and 10 pg/mL phosphoramidon) for 1 to 2 hours. Samples were precleared with Dynabeads (M-280 coated with sheep antimouse Ig) for 1 to 2 hours. Beads were discarded and the lysates incubated for 2 hours with an anti-hTF monoclonal antibody (htfl). The TF/antibody complexes were then immunoprecipitated for 2 hours with Dynabeads, washed thoroughly in lysis buffer, boiled in a reducing sample buffer, and run on 12% SDS-PAGE beside a biotinylated molecular weight standard. Proteins were then blotted onto Immobilon-P nitrocellulose (Millipore). Nonspecific binding was blocked with 3% dry milk, and biotinylated proteins were visualized by binding of streptavidin-biotin-HRP and exposure to Enhanced ChemiLuminescence reagents (ECL; Amersham). The relative intensities of the bands were determined by scanning different exposures in a Shimadzu dual-wavelength flying-spot scanner.
RESULTS
Using the Transwell culture system described, we have recently dernonstratedl6 that TF activity expressed in HU-VEC induced with E-lp is highly polarized to the apical (luminal) surface of the cells. To obtain this apical expression, the endothelial cells must be grown beyond confluence on a permeable support, to a state where junctional complexes are formed and reduced intercellular passage of macromolecules is evident. For comparison, we also used MDCK strain 1, an epithelial cell line that forms stable and well-characterized tight junctions. Transfecting these cells with human TF constructs allowed studies of the sorting of both canine and human TF.
TF Activity in Transient Assays and Stable Clones
Constructs coding for wild-type (hTF.263) and truncated (hW,.245) human TF were transiently transfected into a monkey kidney fibroblast-like cell line (COS-l) that does not normally express TF. In total cell homogenates ( Fig 1A) the truncated clone yielded about 40% higher activity than the wild-type clone, confirming that the cytoplasmic domain of TF is not needed for formation of an active complex with FVII, Ca2', and phospholipids.20 MDCK strain 1 cells were transfected with the same constructs and selected for stable integration with G418. TF activity was tested by coagulation of homogenized cells with human plasma and related to total cell protein (Fig 1B) . MDCK cells expressed significant background levels of canine W, which reacted with human FVII. The clone transfected with the hTF1-245 construct expressed more total TF activity than that transfected with the hnI.263 construct. When these MDCK clones were grown to confluence in normal wells and tested for surface activity using a chromogenic factor Xa-dependent peptide assay, the ratios between the surface and the total activity of each clone (tested by the clotting assay) were similar (Fig 1B and C) , indicating that the truncated TF reached the cell surface as efficiently as the wild-type.
In agreement with studies in other cell lines,18,21,22 we found that the activity of homogenized cells (Fig 1B) was 20-to 30-fold higher than that of intact cells (Fig 1C) . The total surface activity of the clone transfected with the wild-type human TF construct (hTF1.263) was set at 100% (0.43 UTFlrng protein, of which 0.27 UTFlmg protein is due t o human TF). One typical experiment in triplicate (mean t SDI.
TF Surfnce Activie of Stable MDCK Clones Grown on Permeaide Support
The stably transfected MDCK clones and nontransfected MDCK cells were grown on permeable filters, feeding the cells every day from both sides of the cell layer. When tight CAMERER ET AL junctions were confirmed by measurements of transepithelial electrical resistance, the TF activity available on the surface of the cell monolayers was tested on either side using the Xa chromogenic substrate assay.
To separate endogenous canine TF activity from the human TF activity, we first performed experiments where the cells were preincubated with a neutralizing murine anti-human TF monoclonal antibody. This brought the activity of the transfected clones down to the level of nontransfected cells (Fig 2A) . The antibody had no effect on the background canine TF activity. To exclude this background canine TF activity when measuring human TF activity due to transfection in subsequent experiments, the apical or basolateral activity of cells incubated with human TF neutralizing antibody was subtracted from the apical or basolateral activity of the transfected cells a s appropriate. As discussed above, only a limited fraction of the total cellular TF activity of transfected MDCK monolayers was available on the surface. The major part (79% for hTFl.263 or 81% for hTFI.245) of this surface activity was found to be apical (Fig 2B) . The total surface available activity of the cells transfected with hTFl.2,5 relative to that of cells transfected with hTFl.263 was lower in tight layers (Fig 2R) than in subconfluent layers (Fig IC) . This observation was consistent in all experiments and in both hTFI.245 cell clones investigated, and the gradual decrease of hTFI.2A5 surface activity relative to hTFI.26 surface activity could be followed from subconfluence through to the formation of tight junctions.
The total surface available wild-type human TF activity of subconfluent cell layers in normal wells (0.27 U hTFl.26,,/mg cell protein; Fig IC) was similar to that of cells in Transwells (0.24 U hTFl.26,Jmg protein; Fig 2B) , suggesting that surface TF was equally available to our assay system under both culturing conditions. Furthermore, control experiments in Transwells with 3-pm pore size gave essentially the same activity distribution as did Transwells with 0.4-p.m pores.
To determine if the apical predominance of TF activity on MDCK cells was limited to the activation of macromolecular substrate, we also looked at the direct hydrolysis of the peptide substrate S-2288 by TFNIIa (the amidolytic activity) on apical and basolateral surfaces. Figure 2C shows the sum of S-2288 hydrolysis by human and canine TFNlIa on the apical and on the basolateral surface of MDCK hTFl.26,, cells. The figure demonstrates that the amidolytic activity of the complex was greater on the apical surface than on the basolateral, in agreement with what was found for activation of macromolecular substrate (Fig 2B) .
L.ocatior1 of TF Sut$lce Antigen in HUVEC and MDCK
Cells
The apical/basolateral distribution of TF antigen on the surface of polarized monolayers of HUVEC (after 6 hours of IL-Ip stimulation) and MDCK was determined by binding of 1'51-labeled anti-hTF antibodies or ligand FVIIa and by cell surface specific biotinylation followed by irnmunoprecipitation (MDCK cells only).
For binding of iodinated antibodies, intact monolayers were incubated on ice with 1251-labeled monoclonal murine anti-hTF antibody (htfl or 4504) to saturation of TF-specific binding. In preliminary experiments, this was determined to require about 1 hour. Both antibodies gave the same final result, although the htfl antibody gave higher nonspecific binding to both HUVEC and MDCK cells. In HUVEC, 78% ? 5% of the surface available antigen was found on the 1343 apical surface (Fig 3A) . In MDCK cells, the distribution of binding sites was the opposite of that in HUVEC: 94% 2 3% (hTF1.263) or 92% 2 3% (hTFI.24s) of the surface available TF antigen was located on the basolateral surface of the MDCK cells (Fig 3B) . Thus, in HUVEC, TF antigen and activity colocalized to the apical surface of the cell layer. However, in MDCK cells, the situation was different. More than 90% of the surface available TF antigen was detected on the basolateral side, whereas essentially all of the (very limited) TF surface activity was observed on the apical side. This is clearly illustrated in Fig 3C, where the apical and basolateral human TF activity of the MDCK hTFI.263 clone (Fig 2B) was related to the number of apical and basolateral cell surface antibody binding sites on the same clone (Fig 3B) . The specific activity of the basolateral TF was about 100-fold lower than that of the apical TF. All these binding experiments were performed at 4°C. Control experiments at 37°C gave similar results. Comparison of 12sI-labeled antibody binding to intact and ethanol fixed (opened) cells on Transwells revealed that the surface available human TF antigen accounted for 70% i . 8% (n = 10) of the total human TF antigen in the transfected MDCK cells.
Binding of iodinated FVIIa was used as an independent method for determining surface available TF and also allowed determination of the distribution of canine TF. This was especially important in view of the discrepancy in MDCK cells between the very high amount of basolateral TF antigen (94% of total surface available antigen; Fig 3B) and the low basolateral procoagulant activity (less than 20% of total surface available activity; Fig 2B) . Nontransfected cells and cells transfected with hTF1.263 were used. The binding assays were performed in the presence or absence of a 50-fold molar excess of cold FVIIa. The competable binding (binding in the absence of cold FVIIa-binding in its presence) was taken to be the specific binding. These FVIIa binding data ( Fig 3D) demonstrated a distribution of human TF that was similar to that obtained when antibody binding was studied, although the basolateral portion was slightly lower (88% rather than 94% of total surface available). A basolatera1 predominance was found also for the canine TF (84% of the total surface available).
The total number of antibody binding sites on the cell surface was essentially the same for wild-type and truncated human TF in MDCK cells (25.5 5 3.1 and 25.9 ? 4.1 X lo9 antibody binding sites/cm2 filter, respectively, n = 21). The same number of total surface binding sites was found with FVIIa (24.4 2 7.1 X lo9 FVIIa binding sites/cm2 filter, n = 9), suggesting that the number of binding sites corresponded to the number of cell surface TF molecules. The induced endothelial cells had much less TF antigen on their cell surface (3.4 2 0.6 X lo9 antibody binding sites/cm2 filter, n = lo), partly due to the heterogeneity in response to IL-1P discussed below and to the lower number of cells per filter area (DNA content was determined by Hoechst 33258 to be 17 ? 6 pglcm' filter for MDCK cells and 4.7 2 0.8 &cm' filter for HUVEC).
For immunofluorescence studies of subconfluent HUVEC stimulated by IL-lP to synthesize TF, ethanol fixed on glass cover slips and costained with propidium iodide and an antihTF antibody showed marked cell-to-cell heterogeneity of (Fig 5 ) showed a distribution of biotinylated TF antigen to the basolateral (hTF,.263r 94% 5 1%; hTFI.245r 90% t 4%) and apical (hTF1.2n3, 6% 2 1%; hTFI.24s. 10% 2 4%) surface domains essentially identical to that obtained with binding of iodinated monoclonal antibody and FVIIa. Wild-type MDCK gave no recoverable biotinylated TF. 
Redistribution of MDCK TF Activity and Antigen on Treatment With Brefeldin A
In an attempt to induce a shift of the polarity of TF antigen, polarized MDCK cell layers were treated with Brefeldin A (BFA). The concentration used (5 ,ug/mL) would be expected to have an effect on the expression of proteins in MDCK cells under these conditions.".*" By attempting to induce a shift of the TF expression, we wanted to investigate the importance of the local environment for the activity of the TFlFVIIa complex.
The cells were treated with BFA for 6 and 24 hours. After 6 hours, only a slight shift in antibody binding and TF activity toward the apical surface was seen. After 24 hours, total surface binding of the '2'I-labeled monoclonal anti-hTF antibody increased by about 40%, caused by an approximately equal increase in binding sites on the apical and the basolateral side (Fig 6 ) . This resulted in an apical shift from 6% to 8% to about 20% of the total surface binding. Cells transfected with the truncated construct (hTFI.24s) showed a slightly higher increase on the apical side than cells transfected with the complete TF cDNA (hTFI-263). These observations were confirmed by direct surface biotinylation (Fig 7) . Measurements of cell surface Xa generation showed a 2.3 5 0.7-fold increase in apical activity compared with untreated cells, but hardly any (1.3 2 0.2-fold) increase in basolateral activity (n = 12). The corresponding increase in apical antigen (4.0 5 1.2-fold) was not significantly different from this activity increase. These results suggest that it is the local environment of the membrane domain that determines if the expressed TF is active. Treatment with BFA led to moderate cellular shape changes and reduced the electrical resistance by about 50% without causing detectable leakage through the layer, confirming previous observations.*' Fig 38) . Data are the mean of 3 independent experiments, each in triplicate.
Activih of Basolateral TF in MDCK Cells
Basolateral TF in MDCK cells had very low specific activity (Fig 3C) . To study the possible causes, we have looked for TFPI-I and Annexin V by immunofluorescence microscopy. With anti-TFPI-l an almost uniform fluorescence was seen on the basolateral side; all the controls were negative. The fluorescence pattern was compatible with diffuse cellular or matrix staining. On the apical side all cells were unstained except for a few cells growing in dumps or piles. These cells expressed TF and were apparently not polarized. Thus, this antibody to human TFPI-I recognized also the canine factor. TFPI-I expression was essentially observed on the basolateral side. Treatment of the cells with heparin did not change the fluorescence pattern. Neither heparin ( I 0 kD. 
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U/mL for 6 hours) nor a neutralizing polyclonal antibody to human TFPI-I significantly altered the activity of TF on the basolateral side.
Polyclonal antibodies to Annexin V did not disclose any endogenous Annexin V bound to the MDCK surface. However, purified human Annexin V bound to HUVEC and was easily detected using the same polyclonal antibodies. No binding was observed to MDCK cells, neither on the apical nor on the basolateral side, indicating a low content of negatively charged phospholipids in the outer leaflet of the plasma membrane.
DISCUSSION
The binding of FVII to the extracytoplasmic part of TF is an obligatory step in its triggering of blood coagulation.' Recent studies in our laboratory' have shown that TF has a dual function in that FVII binding also elicits an intracellular signal in the form of Ca'' spikes. TF is constitutively expressed in many cell types that are not normally in contact with flowing blood, such as epithelial cells lining the body cavities. In two cell types, monocytes/macrophages and endothelial cells, which are both in contact with flowing blood, TF synthesis can be induced.839 In vivo, epithelial cells and endothelial cells form tight junctions or junctional complexes that seal off an apical surface area from the rest of the surface (basolateralj with regard to lateral diffusion in the cell membrane and thus allow the definition of these two surface domains. In vitro experiments to define characteristics of these domains must consequently be performed under conditions where the formation of such junctional complexes is possible, and only under such conditions can the polarity of TF expression be studied.
TF Is Expressed Mainly on the Luminal Surface of IL-10
Induced Endothelial Cells
By growing cells on permeable filters and carefully monitoring the formation of junctional complexes, we have recently shown that in endothelial cells induced by interleukin-ID, the fraction of total TF activity ( -25%j2x that becomes available for triggering of coagulation on intact cells is mainly on the apical surface.16 In the present report, we confirm this distribution by measurement of binding of a labeled monoclonal antibody to the cell surface domains.
Previous report^^*,^^ have suggested different localizations of TF in endothelial cells at variance with our results and with those of others. As far as we can judge, neither of these groups have grown the endothelial cells on permeable supports (except for EM studies by Ryan et al"), nor have they cultured the cells for the time we find necessary to establish junctional complexes. The differences are thus most likely due to difference in experimental designs. The inadequacy of such setups for the formation of junctional complexes in endothelial cells has also been suggested by Schleef et al. '" If the polarized expression pattern described here also holds true for the in vivo situation, induced TF is uniquely positioned for interacting with FVIIa on the luminal surface of the endothelial cell. An important role is suggested for endothelial TF in the inflammatory response, contributing to an increased prothrombotic state of the endothelium without the requirement for endothelial disruption. This occurs in concert with novel synthesis of leukocyte adhesion molecules (E-selectinj' and vascular cell adhesion molecule-1 '?) and with a decrease in the cell surface fibrinolytic activity (upregulation of luminally expressed type 1 plasminogen activator inhibitor," downregulation of cell surface thrombom~d u l i n~~"~ and tissue-type plasminogen activator productionjx). All these factors would contribute to the initiation and stabilization of fibrin deposition on the perturbed endothelial surface, eg, as part of a disseminated intravascular coagulation process. Whether these in vitro findings reflect what actually takes place in vivo is still in the dark, as expression of TF in perturbed vascular endothelium in vivo (except in spleen) has been hard to demonstrate.23~'y~J" These difficulties may be related to the low level and heterogeneity of T F expression in perturbed endothelial cells, or possibly to masking of the antigen. Even very low levels of T F expression in vivo could still be of pathological significance, eg, by disturbance of the plasma VIIdVlI ratio, once the T F is presented directly to flowing blood as our findings suggest.
TF I s Expressed Mainly on the Basolateral Surface of' MDCK Cells
In contrast to endothelial cells, epithelial cells would be expected to interact with FVII reaching the cell from the basolateral side. Studies of human TF antigen on the surface of transfected MDCK cells showed that 88% to 94% of surface TF indeed was localized to the basolateral side of the cells. The endogenous canine TF in the MDCK cells was distributed in the same way; ie, both the human and canine TF in MDCK cells showed the opposite pattern of what was found for endothelial cells. The difference in localization suggests that the sorting machinery either looks at different sorting signals in MDCK and endothelial cells or reads the same signals to a different conclusion.
The strictly polar expression in both cell types suggests active sorting in both cases rather than active in one and default in the other, although the basolateral dominance in MDCK is reduced when the results are normalized per unit surface area constituting the two domains. Normalized for the ratio of apical to basolateral surface areas (-1:3.8j:' there is still a greater than two-fold basolateral preference for TF antigen expression. This is less compatible with passive delivery to the apical and basolateral membrane domains. Prolonged treatment of the MDCK cells with Brefeldin A caused an apparent redistribution of TF antigen as well as activity toward the apical surface. Whether this is caused by altered sorting of newly synthesized T F or (less likely) represents a true redistribution of basolateral or intracellular TF is not known. It is interesting to note that essentially all of the TF appearing on the apical surface becomes fully active. This local environment thus allows functional expression of an increased number of TF molecules. and by biotinylatiodimmunoprecipitation but was not accompanied by detectable procoagulant activity. This was not a temperature-dependent phenomenon, as the same binding distribution was obtained at 37"C, nor was it due to limited access of activity assay components through the permeable filters, as the same activity distribution was observed with cells grown on large pore (3.0 pm) membranes. It was clear from our binding studies that FVIIa, a molecule similar to FX also used in the Xa chromogenic substrate assay, was able to reach and bind to the basolateral TF. The limited activity of the basolateral TF was not restricted to activation of macromolecular substrate, as a similar lack of activity was found when looking at direct hydrolysis of a peptide substrate (S-2288) by the TFNIIa complex.
Discordant Expression of TF Antigen and Activity on the
It thus appears that there was a large fraction of TFNIIa complexes on the basolateral surface of the MDCK cells which was not active and a much smaller number of complexes on the apical surface which was highly active.
Several different not mutually exclusive explanations are possible. Restricted access of substrates to bind with TF is unlikely as discussed above. The presence of one or more inhibitors is possible. Candidates might be TFPI-1,2,42 TFPI-2 : ' antithrombin III,M Annexin V4' or ~phingosine.~~ The latter two are unlikely; Annexin V was not detected and may not be able to inhibit the TFNIIa complex in intact s u r f a~e s .~~,~' Sphingosine acts by inhibiting binding of VIIa to TF,& which we have found to be unhampered in MDCK cells. Immunofluorescence studies of polar MDCK cell layers clearly showed basolateral localization of TFPI-1. This inhibitor is normally expected to require FXa for binding to the TFNIIa complex, whereas we demonstrate lack of activity of the TFNIIa complex also in the absence of FX.
Another possibility might be the lack of phosphatidylserine (PS) in the outer leaflet of the plasma membrane. PS has previously been shown to be crucial for TF In 1992, Le et a]'' suggested the existence of two classes of TFNIIa complexes on the surface of OC-2008 cells. Both fractions had the same binding affinity, both were active upon cell lysis, but only the minor fraction supported the activation of macromolecular substrate on the cell surface. To explain this, Le et a1 suggested that the recruitment of an additional surface component, essential for the catalytic activity of the TFNIIa complex, was necessary. Cell lysis would supply more of this limiting compound, suggested to be PS. This would be consistent with the absence of binding of Annexin V, but the limited difference in gross composition of apical and basolateral plasma membrane domains" does not support this hypothesis, although a very special distribution of PS between the outer and inner plasmamembrane leaflet" is not excluded.
One should also consider the fact that the increase in apical TF antigen after treatment with BFA was coupled to an increase in activity of the same scale. This would be compatible with a limiting amount of an additional surface 241 1347 component required for activity only if the amount of this component was also affected by BFA treatment or by polarization of the cells.
Removal of the TF Cytoplasmic Tail Does Not Alter the Distribution of TF in MDCK Cells
Until recently, all of the proteins studied which localize to the basolateral domain of MDCK cells, have had active sorting signals within their cytoplasmic domains. Two types oforting motifs have been revealed, one type dependent on a tyrosine residue and the other dependent on a double leucine (or other hydrophobic doublets).53 When these basolateral determinants are deleted, the proteins are distinctly missorted to the apical surface of the ~e l l s .~~~~~ Cytoplasmic domain-independent sorting to the basolateral surface of polarized MDCK cells was recently demonstrated for the (Y2A-adrenergic receptor. 60 The TF cytoplasmic domain does not contain any known signal for endocytosis or sorting. Amino acid sequence alignment of the human, murine, bovine and rabbit TF cytoplasmic domains shows a high degree of conservation comprising a serinekhreonine phosphorylation site6' and several other amino acid residues (Fig 8) . As was the case for the azA-adrenergic receptor,m deletion of the cytoplasmic domain of TF had no obvious effect on surface distribution of the protein; the truncated mutant showed the same basolateral phenotype as wild-type TF. We have not excluded the possibility that the three remaining membrane proximal amino acids of the cytoplasmic tail are of importance, as palmitoylation signals have in some cases been shown to have an effect on endocytosis.62.6' The cytoplasmic tail is not important for sorting of TF, but it may have other roles, such as in the modulation of TF half life on the cell surface or in mediating the intracellular signal generated by TF on binding of its ligand FVIIa.' Why the activity of clones stably transfected with truncated T F C D N A , .~~~ was in fact greater than wild-type transfected clones is not known. Paborsky et a1 made the same observation*' and reported that there was no difference in specific activity between the two. In our studies, both constructs contained the 3' untranslated region of TF cDNA; therefore, it is not likely to be due to different mRNA stability.
Sorting of TF in MDCK cells is also unusual in the sense that although TF does not contain any known basolateral sorting or endocytosis signals, it still sorts to the basolateral domain of the cells. This, in combination with the lack of cytoplasmic tail involvement, raises the possibility of a new class of yet unidentified basolateral sorting signals (if the sorting is indeed active). Together with what was seen for the a,,-adrenergic receptor, this suggests that basolateral sorting in MDCK cells is not always regulated by a cytoplasmic determinant intimately linked to an endocytosis signal.
Prior to this study, there are few studies of sorting of the For personal use only. on August 16, 2017. by guest www.bloodjournal.org From same protein in both endothelial and epithelial cells. GPIanchors have been shown to direct proteins to the apical domain in both polarized endothelial cells64 and MDCK cells.h5 The transferrin receptor is localized on the basolateral surface of MDCK cells,"6 and on the apical surface of the high resistance endothelium of the blood-brain barrier,67 but not the normal low-resistance vascular endothelium.hR Sorting of TF to opposite domains in epithelium and normal lowresistance vascular endothelium remains without precedent. 
